For the three months to 31 December, 2022, Visteon reported net sales up 35% year on year to US$1,064m driven by the ramp up of recently launched products, favourable pricing, and customer vehicle production growth.

Net income was $34m (vs $31m in Q4 2021) and adjusted EBITDA $103million or 9.7% of sales, despite global semiconductor shortages impacting production throughout the quarter. Adjusted EBITDA benefited from “robust” sales and the “ongoing benefits of cost and commercial discipline”.

Full year

Net sales also grew 35% to $3,756m and net income was $124m ($41m).

Adjusted EBITDA was $348m in 2022 or 9.3% of sales, driven by higher sales while “leveraging a lean cost base with modest increases in engineering and other fixed costs”. Visteon added positive pricing mostly offset incremental costs caused by the ongoing global semiconductor shortages and other supply chain challenges.

The supplier said it won $6bn of new business in 2022 and launched 13 new products in Q4 and 45 for all of 2022, which continues to build the foundation for the company’s sustainable market out-performance.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Full year 2023 guidance expects sales in the range of $3.95bn to $4.15bn and adjusted EBITDA $405m-$445m.